Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somapacitan vs Norditropin® in Children Born Small for Gestational Age
NCT03878446Phase 2Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Jul 2019
- Primary completion
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 23
01
Overview
A Phase 2 trial of somapacitan in short stature, sponsored by Novo Nordisk. Started Jul 2019; status: active, not recruiting.
02
Drugs
somapacitan
03
Conditions
short stature
Beyond the preview
Go deeper on NCT03878446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878446.